-transparent.png){kind=logo}
New molecular and immunotherapeutic approaches in biliary cancer. 2017
Department of Medical Oncology at the Nelune Cancer Centre, Prince of Wales Hospital, Sydney, New South Wales, Australia; Prince of Wales Clinical School, University of New South Wales, Sydney, New South Wales, Australia. Electronic address: d.goldstein@unsw.edu.au.
Biliary tract carcinoma is a collective term for a group of rare gastrointestinal cancers. This overview outlines the key pathways and specialised therapeutics in biliary cancer and the emerging role of immunotherapy by highlighting the rationale and selected examples of studies in each area.
| UI | MeSH Term | Description | Entries |
|---|
Related Publications
David Goldstein, and
Charlotte Lemech, and
Juan Valle
July 2017,
Current treatment options in oncology,
David Goldstein, and
Charlotte Lemech, and
Juan Valle
August 2023,
Pathology, research and practice,
David Goldstein, and
Charlotte Lemech, and
Juan Valle
February 1982,
International journal of radiation oncology, biology, physics,
David Goldstein, and
Charlotte Lemech, and
Juan Valle
October 2022,
Hepatobiliary & pancreatic diseases international : HBPD INT,
David Goldstein, and
Charlotte Lemech, and
Juan Valle
January 2008,
Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer,
David Goldstein, and
Charlotte Lemech, and
Juan Valle
January 2019,
Anti-cancer agents in medicinal chemistry,
David Goldstein, and
Charlotte Lemech, and
Juan Valle
August 2015,
Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine,
David Goldstein, and
Charlotte Lemech, and
Juan Valle
January 2021,
Journal of immunology research,
David Goldstein, and
Charlotte Lemech, and
Juan Valle
June 2024,
Immunopharmacology and immunotoxicology,
David Goldstein, and
Charlotte Lemech, and
Juan Valle
November 2015,
World journal of gastrointestinal oncology,
